RT Journal Article
SR Electronic
T1 Predictor of neoplasms and body composition with machine learning models
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.07.23289621
DO 10.1101/2023.05.07.23289621
A1 Fuentes Sebio, Mª Jesús
YR 2023
UL http://medrxiv.org/content/early/2023/05/14/2023.05.07.23289621.abstract
AB Background The tissue microenvironment of neoplastic diseases differs from that of normal cells. Their extracellular matrix, innervation, metabolism, as well as interstitial fluid and intercellular interconnections mark clear physical differences between normal and cancerous cellular ecosystems. Detecting these physical changes early without using diagnostic methods that are harmful and uncomfortable for the patient is a major challenge for the medical-scientific community. Electrical bioimpedance supported by machine learning techniques can provide clues to incipient preneoplastic tissue changes.Methods In this study, 7 predictive machine learning models were developed using a database with bioimpedanciometric data from a group of healthy individuals and another group of patients who had or were suffering from cancer at the time of measurement.Results The Random Forest was the model that reported the best Accuracy, reaching over 90% of hits.Conclusions These results open the door to future research linking changes in body composition and pretumoral tissue environments using machine learning tools.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Dra. Fuentes Medical Nutrition Center gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.